Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: Is there a difference in the elderly?

Texas Heart Institute Journal

Volumn 30, Issue 3, 2003, Pages 176-179

  Mourilhe Rocha, Ricardo ^a   Silva, Guilherme Vianna ^b   Perin, Emerson C ^b,c   Regazzi Gerk, André ^a   Pimentel Gouvea, Elias ^a   Soares Santos, Valéria Martins ^a   Albanesi Filho, Francisco Manes ^a   Campos de Albuquerque, Denilson ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Arrhythmia; Carvedilol; Elderly patients; Electrocardiography; Heart failure, congestive; QT interval dispersion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR EFFECT; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; GERIATRIC PATIENT; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; QT INTERVAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; CARBAZOLES; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0041325327     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ, et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996;17:1390-403.
2. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-4.
3. Higham PD, Hilton CJ, Aitcheson JD, Furniss SS, Bourke JP, Campbell RW. Does QT dispersion reflect dispersion of ventricular recovery [abstract]? Circulation 1992;86(4 Suppl I):I-392.
4. Merx W, Yoon MS, Han J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977;94:603-10.
5. Darbar D, Luck J, Davidson N, Pringle T, Main G, McNeill G, Struthers AD. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ 1996;312:874-9.
6. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9.
7. Tieleman RG, Crijns HJ, Wiesfeld AC, Posma J, Hamer HP, Lie KI. Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J 1995;73:37-40.
8. Higham PD, Furniss SS, Campbell RW. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995;73:32-6.
9. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995;345:945-8.
10. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998;97:467-72.
11. Gillis AM, Traboulsi M, Hii JT, Wyse DG, Duff HJ, McDonald M, Mitchell LB. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation. Am J Cardiol 1998;81:588-93.
12. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997;95:1686-744.
13. Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994;74:550-3.
14. Spargias KS, Lindsay SJ, Kawar GI, Greenwood DC, Cowan JC, Ball SG, Hall AS. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J 1999;20:1158-65.
15. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998;97:2543-50.
16. Naka M, Shiotani I, Koretsune Y, Imai K, Akamatsu Y, Hishida E, et al. Occurrence of sustained increase in QT dispersion following exercise in patients with residual myocardial ischemia after healing of anterior wall myocardial infarction. Am J Cardiol 1997;80:1528-31.
17. Fu GS, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 1997;18:281-9.
18. Pye M, Quinn AC, Cobbe SM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1994;71:511-4.
19. Brooksby P, Batin PD, Nolan J, Lindsay SJ, Andrews R, Mullen M, et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Eur Heart J 1999;20:1335-41.
20. Brendorp B, Elming H, Jun L, Kober L, Malik M, Jensen GB, Torp-Pedersen C. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 2001;103:831-5.
21. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
22. Andersson B, Hamm C, Persson S, Wikstrom G, Sinagra G, Hjalmarson A, Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994;23:1397-404.
23. Rahman MA, Hara K, Daly PA, Wigle ED, Floras JS. Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations. Br Heart J 1995;74:431-6.
24. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, et al. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation 2001;104:2194-9.
25. Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-69.
26. Yildirir A, Sade E, Tokgozoglu L, Oto A. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure. Eur J Heart Failure 2001;3:717-21.
27. Fesmire SI, Marcoux LG, Lyyski DS, Sprague MK, Kennedy HL, Eichhorn EJ. Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 1999;84:350-4,A9.
28. Murray A, McLaughlin NB, Bourke JP, Doig JC, Furniss SS, Campbell RW. Errors in manual measurement of QT intervals. Br Heart J 1994;71:386-90.
29. Savelieva I, Yi G, Guo X, Hnatkova K, Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol 1998;81:471-7.
30. Glancy JM, Weston PJ, Bhullar HK, Garratt CJ, Woods KL, de Bono DP. Reproducibility and automatic measurement of QT dispersion. Eur Heart J 1996;17:1035-9.